Gadobutrol (INN An International Nonproprietary Name is the official non-proprietary or generic name given to a pharmaceutical substance, as designated by the World Health Organization (WHO)[citation needed]. The plethora of named proprietary preparations containing a given substance can lead to confusion about the identity of the active ingredient. INNs) is a contrast agent.
References
- Vogler H, Platzek J, Schuhmann-Giampieri G, et al. (November 1995). "Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging". Eur J Radiol 21 (1): 1–10. doi A digital object identifier is a character string used to uniquely identify an electronic document or other entity. The DOI for a document remains fixed over the lifetime of the document, unlike URLs which can change when a publisher of online content changes its web server's file structure, and the DOI System provides a mechanism for locating an:10.1016/0720-048X(95)00679-K. PMID A PMID is a unique number assigned to each PubMed citation of life sciences and biomedical scientific journal articles. The related Pubmed Central archive may additionally assign a separate number, a PMCID (PubMed Central Identifier), normally written with a PMC prefix 8654452. http://linkinghub.elsevier.com/retrieve/pii/0720-048X(95)00679-K.
- Laniado M, Kopp AF (December 1997). "[Current status of the clinical development of MR contrast media]" (in German). Rofo 167 (6): 541–50. PMID A PMID is a unique number assigned to each PubMed citation of life sciences and biomedical scientific journal articles. The related Pubmed Central archive may additionally assign a separate number, a PMCID (PubMed Central Identifier), normally written with a PMC prefix 9465947.
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Categories: Radiocontrast agents | Gadolinium compounds |
|